Woojin B&G Accelerates Expansion into Central and South American Veterinary Pharmaceutical Markets

Woojin B&G, a company specializing in veterinary pharmaceuticals, announced on August 21 that it has completed the registration of its porcine epidemic diarrhea (PED) vaccine 'PED-M' for product approval in Mexico.

Woojin B&G plans to accelerate its entry into the Central and South American markets, including Mexico, following its current exports to Thailand. Previously, in July, Woojin B&G was dispatched as part of a market development delegation to Chile and Mexico in cooperation with the Ministry of Agriculture, Food and Rural Affairs. The government's support, aimed at eliminating institutional barriers and establishing a foundation for export expansion, is also expected to be of significant help.

In addition, Woojin B&G's IMMUNIS PED-M is expected to receive approval in Vietnam within this year, following Mexico, further expanding its overseas market opportunities.

A Woojin B&G representative stated, "By securing product approval for sales in Mexico following Thailand, our global sales network has expanded," adding, "We expect export performance to exceed 10 billion KRW by the end of the year through additional approvals in countries such as Vietnam."

This content was produced with the assistance of AI translation services.